HK51396A - Direct compression cholestyramine tablet and solvent-free coating therefor - Google Patents

Direct compression cholestyramine tablet and solvent-free coating therefor

Info

Publication number
HK51396A
HK51396A HK51396A HK51396A HK51396A HK 51396 A HK51396 A HK 51396A HK 51396 A HK51396 A HK 51396A HK 51396 A HK51396 A HK 51396A HK 51396 A HK51396 A HK 51396A
Authority
HK
Hong Kong
Prior art keywords
solvent
direct compression
free coating
coating therefor
cholestyramine
Prior art date
Application number
HK51396A
Other languages
English (en)
Inventor
Robert J Bequette
Bruce A Bonenberger
Claude E Gallian
John R Reckelhoff
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of HK51396A publication Critical patent/HK51396A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/282Organic compounds, e.g. fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/2853Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
HK51396A 1989-03-16 1996-03-21 Direct compression cholestyramine tablet and solvent-free coating therefor HK51396A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/324,167 US4956182A (en) 1989-03-16 1989-03-16 Direct compression cholestyramine tablet and solvent-free coating therefor

Publications (1)

Publication Number Publication Date
HK51396A true HK51396A (en) 1996-03-29

Family

ID=23262387

Family Applications (1)

Application Number Title Priority Date Filing Date
HK51396A HK51396A (en) 1989-03-16 1996-03-21 Direct compression cholestyramine tablet and solvent-free coating therefor

Country Status (34)

Country Link
US (1) US4956182A (de)
EP (1) EP0387885B1 (de)
JP (1) JP2974719B2 (de)
KR (1) KR0140211B1 (de)
CN (1) CN1047935C (de)
AR (1) AR246012A1 (de)
AT (1) ATE128031T1 (de)
AU (1) AU617601B2 (de)
BG (1) BG60501B1 (de)
CA (1) CA2012300A1 (de)
CS (1) CS277488B6 (de)
CY (1) CY1899A (de)
DD (1) DD292837A5 (de)
DE (1) DE69022452T2 (de)
DK (1) DK0387885T3 (de)
EG (1) EG19669A (de)
ES (1) ES2078917T3 (de)
FI (1) FI92464C (de)
GR (1) GR3017460T3 (de)
HK (1) HK51396A (de)
HU (1) HU209958B (de)
IE (1) IE70591B1 (de)
IL (1) IL93720A0 (de)
MY (1) MY109744A (de)
NO (1) NO176043C (de)
NZ (1) NZ232864A (de)
OA (1) OA09198A (de)
PL (1) PL163301B1 (de)
PT (1) PT93452B (de)
RO (1) RO106953B1 (de)
RU (1) RU2069558C1 (de)
YU (1) YU52390A (de)
ZA (1) ZA902001B (de)
ZW (1) ZW1890A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5372823A (en) * 1989-03-16 1994-12-13 Bristol-Myers Squibb Company Direct compression cholestyramine tablet and solvent-free coating thereof
US5262167A (en) * 1990-12-20 1993-11-16 Basf Corporation Edible, non-baked low moisture cholestyramine composition
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
ATE236639T1 (de) * 1994-09-22 2003-04-15 Akzo Nobel Nv Verfahren zur herstellung von dosierungsformen durch feuchtgranulierung
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
JP4613275B2 (ja) 1998-11-02 2011-01-12 エラン ファーマ インターナショナル,リミティド 多粒子改質放出組成物
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
KR20130010512A (ko) 1999-10-29 2013-01-28 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
KR100960200B1 (ko) 2000-10-30 2010-05-27 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
CA2434835A1 (en) * 2001-02-13 2002-08-22 Astrazeneca Ab Novel modified released formulation
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US20040062804A1 (en) 2001-09-28 2004-04-01 Der-Yang Lee Modified release dosage forms
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
EP1765307B1 (de) * 2004-05-24 2012-11-21 Mepha Schweiz AG Trockenbeschichtungsverfahren
CA2584547C (en) * 2004-10-19 2014-07-08 Miha Vrbinc Solid pharmaceutical composition comprising donepezil hydrochloride
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US8986669B2 (en) 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
EP3000460A1 (de) 2005-09-15 2016-03-30 Genzyme Corporation Beutelformulierung für aminpolymere
DE102005060377A1 (de) * 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
WO2008018556A1 (en) 2006-08-09 2008-02-14 Mitsubishi Tanabe Pharma Corporation Tablet
JP2010504975A (ja) 2006-09-29 2010-02-18 ゲンズイメ コーポレーション アミドデンドリマー組成物
BRPI0720234A2 (pt) 2006-12-14 2013-12-24 Genzyme Corp Composição farmacêutica
CA2864738C (en) 2012-04-18 2017-07-18 Mallinckrodt Llc Immediate release, abuse deterrent pharmaceutical compositions
EP3064352B1 (de) 2013-10-25 2018-04-18 Kuraray Co., Ltd. Mehrschichtfolie und zwischenfolie für verbundglas daraus
JP6850131B2 (ja) 2014-07-03 2021-03-31 スペックジーエックス エルエルシー 非セルロース多糖を含む、乱用抑止性即時放出製剤
CA3011595C (en) * 2016-02-09 2024-01-02 Albireo Ab Cholestyramine pellets and methods for preparation thereof
WO2017138877A1 (en) * 2016-02-09 2017-08-17 Albireo Ab Oral cholestyramine formulation and use thereof
US11478426B2 (en) 2018-09-25 2022-10-25 SpecGx LLC Abuse deterrent immediate release capsule dosage forms
CN114053234A (zh) * 2021-12-29 2022-02-18 江苏省药物研究所有限公司 一种阿卡波糖片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB595444A (en) * 1945-07-09 1947-12-04 Gwilym Lloyd Thomas Improvements in or relating to medicaments, and to the preparation thereof
US3383237A (en) * 1964-01-29 1968-05-14 Richardson Merrell Inc Tablet coating
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
US4895723A (en) * 1986-09-08 1990-01-23 Amer And Company Cholestyramine compositions and method for preparation thereof
ZA876640B (en) * 1986-09-26 1988-03-08 Warner-Lambert Company Treated lipid regulator
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale

Also Published As

Publication number Publication date
IE900941L (en) 1990-09-16
KR0140211B1 (ko) 1998-06-01
PT93452B (pt) 1996-12-31
ES2078917T3 (es) 1996-01-01
PT93452A (pt) 1990-11-07
BG91463A (bg) 1993-12-24
CS277488B6 (en) 1993-03-17
NO176043C (no) 1995-01-25
AU5136790A (en) 1990-09-20
US4956182A (en) 1990-09-11
HU901429D0 (en) 1990-06-28
CY1899A (en) 1990-03-15
OA09198A (fr) 1992-06-30
FI901241A0 (fi) 1990-03-13
GR3017460T3 (en) 1995-12-31
NO901183D0 (no) 1990-03-14
CN1047935C (zh) 2000-01-05
AU617601B2 (en) 1991-11-28
BG60501B1 (bg) 1995-06-30
FI92464C (fi) 1994-11-25
ATE128031T1 (de) 1995-10-15
CA2012300A1 (en) 1990-09-16
RO106953B1 (ro) 1993-08-30
ZA902001B (en) 1990-11-28
HU209958B (en) 1994-12-28
EG19669A (en) 1995-08-30
EP0387885B1 (de) 1995-09-20
JP2974719B2 (ja) 1999-11-10
CN1045921A (zh) 1990-10-10
KR900013946A (ko) 1990-10-22
DE69022452D1 (de) 1995-10-26
DD292837A5 (de) 1991-08-14
NO176043B (no) 1994-10-17
MY109744A (en) 1997-05-31
EP0387885A2 (de) 1990-09-19
PL163301B1 (en) 1994-03-31
ZW1890A1 (en) 1990-10-31
EP0387885A3 (de) 1992-06-17
RU2069558C1 (ru) 1996-11-27
YU52390A (en) 1991-10-31
DK0387885T3 (da) 1995-11-06
NZ232864A (en) 1992-04-28
IE70591B1 (en) 1996-12-11
DE69022452T2 (de) 1996-03-14
HUT54489A (en) 1991-03-28
AR246012A1 (es) 1994-03-30
IL93720A0 (en) 1990-12-23
NO901183L (no) 1990-09-17
FI92464B (fi) 1994-08-15
JPH03236326A (ja) 1991-10-22

Similar Documents

Publication Publication Date Title
EG19669A (en) Direct compression cholestyramine tablet and solvent - free coating therefor
AU626396B2 (en) Composition and use
HK1018161A1 (en) Journal-less rotary dies and stand
IL88986A0 (en) Combined reactive and passive armour
EP0420461A3 (en) Portable and dynamic distributed applications architecture
EP0343526A3 (en) Novel polymer and its preparation and use
EP0426408A3 (en) Combined container and pump
AU633294B2 (en) Motilin-like polypeptide and use thereof
EP0465561A4 (en) Avirulent microbes and uses therefor
EP0393478A3 (en) Gel transfer process and composite
ZA903409B (en) Maleinimide-derivatives and their use as pharmaceuticals
EP0436080A3 (en) Core-shell polymer and its use
GB8911271D0 (en) Holographic devices and uses thereof
EP0259644A3 (en) Impregnating agent and application thereof
ZA907336B (en) Application aid and the use thereof
AU4588189A (en) Imidazole-containing peptide and preparation thereof
GB8922682D0 (en) Waterproofing and lining membrane
GB8900172D0 (en) Market research systems and equipment
GB8920114D0 (en) Application and hinge
PL287389A1 (en) Sealing and coating compounds
ZA942246B (en) Novel imidazolo-quinoxalinones their preparation and use
EP0420811A3 (en) Phosphor containing copolymers and their use
AU5438090A (en) Cyclohexadienediols and their use
RO102974B1 (en) Electro-insulated epoxy-phenolic and fireproof lacquer
IE891418L (en) Fluoroavermectins and fluoromilbemycins

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20100314